StockData

KALA BIO, Inc. (KALA) KPIs and segments

KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 6/30
$0.14−0.02 (-13.79%)

Close on Nov 13, 2026Market cap $2.68MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Kala Bio's business

Coming soon

This tab will track the numbers specific to Kala Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?